These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 12109933)

  • 21. [Current therapeutic strategies in smoking cessation].
    Borgne A; Aubin HJ; Berlin I
    Rev Prat; 2004 Nov; 54(17):1883-93. PubMed ID: 15655912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.
    Stapleton J; West R; Hajek P; Wheeler J; Vangeli E; Abdi Z; O'Gara C; McRobbie H; Humphrey K; Ali R; Strang J; Sutherland G
    Addiction; 2013 Dec; 108(12):2193-201. PubMed ID: 23859696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
    Piper ME; Cook JW; Schlam TR; Jorenby DE; Baker TB
    Addiction; 2011 Feb; 106(2):418-27. PubMed ID: 20973856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of prior nicotine replacement therapy on smoking cessation efficacy.
    Durcan MJ; White J; Jorenby DE; Fiore MC; Rennard SI; Leischow SJ; Nides MA; Ascher JA; Johnston JA
    Am J Health Behav; 2002; 26(3):213-20. PubMed ID: 12018757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New medications for nicotine dependence treatment.
    Hurt RD
    Nicotine Tob Res; 1999; 1 Suppl 2():S175-9; discussion S207-10. PubMed ID: 11768177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suitability of bupropion SR for nicotine-dependent smokers: problems in a practice setting.
    Kohlenberg BS; Antonuccio DO; Hayes SC; Gifford EV; Piasecki MP
    Psychother Psychosom; 2004; 73(4):252-4. PubMed ID: 15184720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
    Tønnesen P; Tonstad S; Hjalmarson A; Lebargy F; Van Spiegel PI; Hider A; Sweet R; Townsend J
    J Intern Med; 2003 Aug; 254(2):184-92. PubMed ID: 12859700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia.
    Wardman AE; Khan N
    Nicotine Tob Res; 2004 Aug; 6(4):689-92. PubMed ID: 15370165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
    Swan GE; Jack LM; Curry S; Chorost M; Javitz H; McAfee T; Dacey S
    Nicotine Tob Res; 2003 Dec; 5(6):911-21. PubMed ID: 14668075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bupropion: risks and benefits.
    Ross S; Williams D
    Expert Opin Drug Saf; 2005 Nov; 4(6):995-1003. PubMed ID: 16255659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
    Saxon AJ; Baer JS; Davis TM; Sloan KL; Malte CA; Fitzgibbons K; Kivlahan DR
    Nicotine Tob Res; 2003 Aug; 5(4):589-96. PubMed ID: 12959797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking cessation treatment in a real-life setting: the Greek experience.
    Rovina N; Nikoloutsou I; Dima E; Michailidou M; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2007 Dec; 1(2):93-104. PubMed ID: 19124351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
    Bergmann L; Warncke W; Herschel M
    Pneumologie; 2004 Mar; 58(3):140-6. PubMed ID: 15007784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2005 Nov; 183(1):1-12. PubMed ID: 16160876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.
    Leeman RF; Huffman CJ; O'Malley SS
    Alcohol Alcohol; 2007; 42(3):196-206. PubMed ID: 17526629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
    Song F; Raftery J; Aveyard P; Hyde C; Barton P; Woolacott N
    Med Decis Making; 2002; 22(5 Suppl):S26-37. PubMed ID: 12369228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation.
    White WD; Crockford D; Patten S; El-Guebaly N
    Nicotine Tob Res; 2005 Oct; 7(5):809-13. PubMed ID: 16191752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.